Celexa (citalopram) frequently reduces libido, and the effect is not subtle. In one large trial of citalopram-treated patients with depression, over half reported a decrease in sexual desire.1PubMed Central. Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed Patients The problem extends beyond desire alone and can touch nearly every phase of sexual response, which makes it one of the more common and frustrating side effects people deal with on this medication.
How Often Celexa Causes Sexual Side Effects
The best data on citalopram specifically comes from the STAR*D trial, one of the largest real-world depression treatment studies ever conducted. Among roughly 1,500 participants taking citalopram, about 54% reported decreased libido and about 36% reported difficulty reaching orgasm.2PubMed Central. Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed Patients About a quarter of participants reported both problems simultaneously, and among the men in the study, roughly 37% experienced erectile dysfunction on top of those other issues. These numbers are broadly consistent with the wider SSRI class, where published estimates put the rate of treatment-related sexual dysfunction somewhere between 30% and 60%.3Annals of Pharmacotherapy. Antidepressant-induced sexual dysfunction
Those figures already sound high, but the real rate may be higher still. In clinical trials, patients are directly asked about sexual function on structured questionnaires, which draws out problems people might not mention unprompted. Pharmacovigilance databases, where patients or doctors voluntarily report side effects, tell a strikingly different story. A French analysis of spontaneous adverse-event reports found that sexual disorders accounted for less than 1% of all reported side effects for serotonin reuptake inhibitors, even though more targeted studies consistently find rates above 50%.4PubMed. Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database The gap reflects the obvious: people are reluctant to bring up sexual problems on their own, which means the side effect is systematically underreported in everyday medical practice.
Why Celexa Dampens Desire
Celexa works by blocking the reabsorption of serotonin in the brain, which raises serotonin levels in the gaps between nerve cells. That boost in serotonin is what helps relieve depression and anxiety, but serotonin also plays a role in regulating sexual arousal, desire, and the ability to reach orgasm. Higher serotonin activity in certain brain pathways can effectively put the brakes on sexual response. A pharmacovigilance study analyzing FDA adverse-event data found that binding activity at the serotonin transporter, the 5-HT1B receptor, and the 5-HT2A receptor all correlated with reports of reduced sexual desire.5Expert Opinion on Drug Safety. The antidepressants and sexual dysfunction: a pharmacovigilance-pharmacodynamic study of the FDA adverse event reporting system In plain terms, the same chemical action that makes Celexa effective against depression also tamps down the brain’s interest in sex.
There are also hormonal effects downstream of serotonin changes. Animal research on citalopram has shown that the drug can raise prolactin and the stress hormone corticosterone. In a study of female rats, citalopram increased prolactin levels and caused measurable damage to ovarian tissue.6Reproductive Toxicology. Hormonal mechanism and pathogenetic therapy of citalopram-induced infertility in female rats Elevated prolactin is known to suppress libido in humans as well, which is one reason some people on SSRIs notice a particularly flat, disinterested feeling rather than just a mild dip in desire. The interplay between serotonin, prolactin, and stress hormones means Celexa is not pressing a single off-switch but disrupting several systems at once.
Who Is More Likely to Be Affected
Not everyone on Celexa experiences the same degree of sexual side effects, and the STAR*D data offers some clues about who is at higher risk. Being male, being married, having a more severe depression at baseline, and having an earlier age of illness onset were all associated with a greater chance of decreased libido.7PubMed Central. Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed Patients The marriage connection may seem odd at first, but it likely reflects the fact that people in ongoing sexual relationships are more attuned to changes in desire than people who are not sexually active.
Genetics also play a part. Researchers looking at the STAR*D population found that variations in two genes involved in how the brain responds to the neurotransmitter glutamate, called GRIA3 and GRIK2, were significantly associated with citalopram-related libido loss. People carrying certain risk variants in GRIK2 had a roughly 30 to 40% greater chance of decreased libido, and those with GRIA3 risk variants had a 20 to 30% greater risk.8PubMed Central. Pharmacogenetics of SSRIs and Sexual Dysfunction This does not mean a genetic test before starting Celexa is standard practice yet, but it does help explain why two people on the same dose can have wildly different experiences. Your brain’s wiring influences how susceptible you are, independent of the drug dose or how depressed you are.
Untangling the Drug from the Depression
This is where things get genuinely tricky, because depression itself is a well-known libido killer. Loss of interest in sex, difficulty with arousal, and inability to enjoy physical pleasure are all common symptoms of major depression. So when you start Celexa and notice your libido has dropped, it is not always obvious whether the drug is making things worse, whether the depression was already suppressing desire, or whether both are contributing.
The STAR*D findings shed some indirect light on this: more severe depression at the time of starting citalopram was itself a risk factor for reporting decreased libido during treatment.9PubMed Central. Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed Patients That suggests the two causes layer on top of each other. Someone whose depression is already flattening their desire may find that Celexa pushes things further in the same direction, even as it starts to help their mood. The practical takeaway is that if your libido was already low before starting the medication, the drug alone may not be the whole story, and improving your depression through continued treatment could eventually help with desire even if the SSRI itself works against it.
One useful clue is timing. If you had a functioning sex drive before starting Celexa and noticed a clear drop within the first few weeks of treatment, the drug is the most likely culprit. If your desire was already low and stayed low, the picture is murkier. Either way, the conversation is worth having with your prescriber, because the distinction matters for choosing a management strategy.
What You Can Do About It
There are several practical approaches, and the right one depends on how well Celexa is working for your depression and how much the sexual side effects bother you.
- Adding bupropion: Bupropion (Wellbutrin) works on dopamine and norepinephrine rather than serotonin, and both controlled and open-label studies support its ability to reverse SSRI-related sexual dysfunction. The combination of bupropion with an SSRI is generally well tolerated and can reduce sexual side effects while also boosting the antidepressant response.10PubMed. Use of bupropion in combination with serotonin reuptake inhibitors This is one of the more commonly tried strategies in clinical practice.
- Switching antidepressants: Not all antidepressants carry the same sexual side-effect burden. The rate and severity of sexual dysfunction varies between drugs, and some medications have meaningfully lower rates, presumably because of differences in how they act on neurotransmitter systems.11CNS Drugs. Impact of Antidepressant Drugs on Sexual Function and Satisfaction Bupropion on its own, mirtazapine, and vilazodone are among the options often discussed as alternatives with lower rates of sexual problems. Switching is not without risk, though: if Celexa is working well for your depression, trying a different drug means accepting the possibility that the new one may not work as well for your mood.
- Dose reduction: Some people find that lowering their dose eases the sexual side effects while still controlling their depression. This only works within a window, as dropping the dose too low can bring depressive symptoms back.
- Timing adjustments: Taking Celexa at a different time of day, or briefly scheduling sexual activity before taking your daily dose when blood levels are at their lowest, is occasionally suggested. The evidence for this is largely anecdotal rather than from controlled trials, but some people find it helpful.
None of these strategies is guaranteed, and the research is candid about the fact that current interventions for antidepressant-related sexual dysfunction are far from perfect.12CNS Drugs. Impact of Antidepressant Drugs on Sexual Function and Satisfaction What matters most is that you and your prescriber are actually having the conversation, because the default outcome, where neither side brings it up and you silently suffer or stop taking the medication, is the worst-case scenario for both your mental health and your sex life.
When Sexual Side Effects Outlast the Medication
Most SSRI-related sexual dysfunction resolves within weeks to months of stopping the drug. But for a poorly understood subset of people, it does not. This condition, called post-SSRI sexual dysfunction (PSSD), involves sexual symptoms that persist long after the medication is discontinued. The most common features include genital numbness, weak or pleasureless orgasm, loss of libido, and erectile dysfunction.13PubMed Central. Post-SSRI sexual dysfunction: barriers to quantifying incidence and prevalence
Citalopram specifically has appeared in published case reports of PSSD. One documented case involved a man who experienced persistent loss of libido, genital numbness, pleasureless ejaculation, and erectile dysfunction after taking 20 mg of citalopram daily for 18 months, with symptoms continuing well after he stopped the drug.14The Journal of Sexual Medicine. Persistent Sexual Dysfunction after Discontinuation of Selective Serotonin Reuptake Inhibitors The exact number of people affected by PSSD remains unknown, largely because quantifying incidence has been hampered by inconsistent definitions, a lack of large prospective studies, and the same underreporting problem that plagues the side effect while people are still on the drug.15PubMed Central. Post-SSRI sexual dysfunction: barriers to quantifying incidence and prevalence
PSSD is not something you should lose sleep over before starting Celexa. Most people’s sexual function does recover after discontinuation. But knowing it exists can help you advocate for yourself: if you stop taking citalopram and your sexual side effects do not resolve after a reasonable period, PSSD is a recognized phenomenon, not something you are imagining, and it is worth raising with your doctor rather than dismissing.
Why So Few Patients Bring It Up
Given how common this side effect is, you might expect it to be a routine topic between patients and prescribers. It is not. In a cross-sectional survey of people taking antidepressants for self-reported depression, fewer than half had discussed sexual dysfunction with their doctor.16Neurology, Psychiatry and Brain Research. Real-world patient experience with sexual dysfunction and antidepressant use in patients with self-reported depression The likely reasons include embarrassment and a sense that sexual function is not a high-priority concern compared to treating depression.
Qualitative research paints a more detailed picture. A study exploring how women cope with SSRI-related sexual side effects identified recurring themes: women described a period of “searching” to understand what was happening, followed by “suffering in silence,” then “trying to resolve” the issue, and eventually “accepting what is.”17Psychology & Health. Women’s experiences of coping with the sexual side effects of antidepressant medication The progression from confusion to resignation is not a recipe for getting help. Many people who land on the “accepting” stage have never had a single conversation with their prescriber about whether something could be done.
The silence runs both ways. Prescribers often do not proactively ask about sexual function at follow-up visits, particularly when using brief medication-check appointments. If the patient does not volunteer the information and the doctor does not ask, a treatable side effect stays invisible. The French pharmacovigilance data confirms the systemic nature of this gap, with spontaneous reports capturing less than 1% of what structured research consistently finds.18PubMed. Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database If you are on Celexa and experiencing changes in your sex drive, the most useful thing you can do is bring it up yourself. It is not a trivial complaint, it is one of the most common reasons people stop taking their antidepressant, and your prescriber has options to offer if they know the problem exists.
How Genetics Could Change Future Prescribing
The discovery that specific gene variants in GRIA3 and GRIK2 predict citalopram-related libido loss hints at a future where prescribers might use a simple genetic test to estimate your risk before writing the prescription. In the STAR*D cohort, people carrying risk variants in GRIK2 had a 30 to 40% higher chance of experiencing decreased libido on citalopram, and those with GRIA3 variants had a 20 to 30% higher chance.19PubMed Central. Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed Patients Both genes are involved in glutamate signaling, not serotonin directly, which suggests the sexual side effects of SSRIs are not purely a serotonin story. The brain’s excitatory signaling system may determine how much the serotonin boost disrupts sexual circuits.
Pharmacogenomic testing is already available for some aspects of antidepressant prescribing, mainly to predict how quickly someone metabolizes a drug. Testing for sexual side-effect susceptibility is not yet part of standard clinical panels. The findings need replication in other populations, and the effect sizes, while meaningful, are not large enough to make a definitive yes-or-no prediction for an individual. Still, the research points toward a world where the choice between antidepressants is guided not just by mood efficacy but by a realistic estimate of what each drug is likely to do to your sex life. For now, the practical value of these genetic findings is mostly explanatory: if Celexa hit your libido hard while a friend on the same dose had no problems, it is not just in your head. Your biology played a role.